��������

Jakob Knudsen is the CEO of Virogates A/S (NASDAQ “VIRO”), an international diagnostics company located in Denmark and is, in addition, a non-executive director in PV Fonden (DK). He holds a Master of Law from the University of Copenhagen, DK, and an MBA from Imperial College, UK. Following his graduation in 1994, Jakob Knudsen has built up extensive experience in commercial operations, including business development, marketing and finance.

He has held various positions at ALK-Abelló A/S, a listed mid-sized biotechnology company in Denmark, where he a.o. headed Corporate Business Development. Furthermore, he has held positions as CCO and CFO at the Danish pharmaceutical company Egalet Ltd.

Jakob Knudsen is an independent member of the board.